Disseny i construcció d'un ribozima de tipus hairpin per a la degradació de la regió 5 UTR del virus de l'hepatitis C. Assaig de l'activitat in vitro i en cultiu

  • Esteban Mur, Juan Ignacio (Principal Investigator)
  • Martell Pérez-Alcalde, María Nieves (Researcher on contract)
  • Guardia Masso, Jaime (Investigator)
  • Gómez Castilla, Jordi (Researcher on contract)
  • Viladomiu Cata, Luis (Researcher on contract)

Project Details


The hepatitis C virus (HCV) is the most common cause of chronic viral infection in Spain and is the causative agent of the majority of cases of chronic liver disease and hepatocellular carcinoma. The prevalence of chronic hepatitis C in Spain is close to 3% of the general population. Currently, the only available treatment for chronic HCV infection, the interferons, can only induce transient remission in about 50% of treated patients and sustained remission in no more than 25%. The main goal of the present project is the design of specific ribozimes capable to cleave and inactivate the 5'NTR of the HCV genome, which is the best conserved region among and within isolates, and is essential for translation and viral replication. Once synthesized, the specificity and catalytic potential of the ribozime will be tested in transient expression systems (HeLa cells transfected with a 5'UTR-CAT co
Effective start/end date7/06/947/06/97


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.